Page last updated: 2024-08-21

alpha-aminopyridine and Centriacinar Emphysema

alpha-aminopyridine has been researched along with Centriacinar Emphysema in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjamin, JT; Blackwell, TS; Cheng, DS; Du, RH; Gleaves, L; Guo, M; Han, W; McKissack, A; Polosukhin, VV; Richmond, BW; van der Meer, R; Zhang, Y1
Antoniu, SA1
Abdolrasulnia, R; Blackwell, TS; Bordenstein, SR; Brucker, RM; Cheng, DS; Clark, PE; Du, RH; Gleaves, L; Han, W; Polosukhin, VV; Polosukhina, D; Richmond, BW; Zhang, Y1
Beume, R; De Cunto, G; Lucattelli, M; Lungarella, G; Lunghi, B; Martorana, PA1
Cortijo Gimeno, J; Morcillo Sánchez, E1
Cortijo Gimeno, J1
Aoshiba, K; Azuma, A; Mizushima, T; Sato, K; Tanaka, K1
Almagro, P; Ancochea, J; Calle, M; López-Campos, JL; Miravitlles, M; Molina, J; Piñera, P; Quintano, JA; Riesco, JA; Simón, A; Soler-Cataluña, JJ; Soriano, JB; Trigueros, JA1
Beume, R; Lucattelli, M; Lungarella, G; Martorana, PA; Wollin, L1

Reviews

2 review(s) available for alpha-aminopyridine and Centriacinar Emphysema

ArticleYear
[Pharmacological profile of roflumilast].
    Archivos de bronconeumologia, 2010, Volume: 46 Suppl 10

    Topics: Airway Remodeling; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Division; Cilia; Cyclopropanes; Drug Evaluation, Preclinical; Fibroblasts; Humans; Hypertension, Pulmonary; Macrophages; Mice; Molecular Structure; Mucus; Myocytes, Smooth Muscle; Neutrophils; Nicotiana; Oxidants; Oxidative Stress; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Smoke

2010
[Phosphodiesterase 4 inhibitors: a new pharmacologic group in the treatment of chronic inflammation of the airways].
    Archivos de bronconeumologia, 2010, Volume: 46 Suppl 9

    Topics: Aminopyridines; Anti-Inflammatory Agents; Benzamides; Cilia; Cyclic AMP; Cyclic GMP; Cyclopropanes; Humans; Inflammation; Isoenzymes; Mucins; Oxidative Stress; Phosphodiesterase 4 Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Second Messenger Systems

2010

Other Studies

7 other study(ies) available for alpha-aminopyridine and Centriacinar Emphysema

ArticleYear
Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.
    American journal of respiratory cell and molecular biology, 2018, Volume: 58, Issue:6

    Topics: Airway Remodeling; Aminopyridines; Animals; Bacillus; Benzamides; Cyclopropanes; Disease Models, Animal; Mice, Inbred C57BL; Mice, Mutant Strains; Neutrophils; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptors, Cell Surface

2018
Phenotype/endotype-driven therapy in COPD: potential economic implications.
    Expert review of pharmacoeconomics & outcomes research, 2013, Volume: 13, Issue:4

    Topics: Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchitis, Chronic; Bronchodilator Agents; Cost-Benefit Analysis; Cyclopropanes; Disease Progression; Drug Costs; Forced Expiratory Volume; Humans; Lung; Patient Selection; Phenotype; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Treatment Outcome

2013
Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
    Nature communications, 2016, Apr-05, Volume: 7

    Topics: Aging; Airway Remodeling; Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunity, Innate; Immunoglobulin A, Secretory; Leukocyte Elastase; Lung; Matrix Metalloproteinase 12; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; NF-kappa B; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptors, Polymeric Immunoglobulin; Respiratory Mucosa

2016
Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice.
    BMC pulmonary medicine, 2008, Aug-28, Volume: 8

    Topics: Aminopyridines; Animals; B-Lymphocytes; Benzamides; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclopropanes; Dendritic Cells; Dose-Response Relationship, Drug; Immunity, Innate; Immunohistochemistry; Lung; Male; Mice; Mice, Inbred C57BL; Models, Animal; Neutrophils; Peroxidase; Phosphodiesterase Inhibitors; Pulmonary Emphysema; T-Lymphocytes; Tobacco Smoke Pollution

2008
Superiority of PC-SOD to other anti-COPD drugs for elastase-induced emphysema and alteration in lung mechanics and respiratory function in mice.
    American journal of physiology. Lung cellular and molecular physiology, 2012, Jun-15, Volume: 302, Issue:12

    Topics: Administration, Inhalation; Airway Resistance; Aminopyridines; Androstadienes; Animals; Benzamides; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Cyclopropanes; Fluticasone; Forced Expiratory Volume; Ipratropium; Lung; Mice; Pancreatic Elastase; Phosphatidylcholines; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Respiratory Physiological Phenomena; Superoxide Dismutase; Superoxides; Vital Capacity

2012
Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
    Archivos de bronconeumologia, 2012, Volume: 48, Issue:7

    Topics: Adrenal Cortex Hormones; alpha 1-Antitrypsin; Aminopyridines; Anti-Bacterial Agents; Asthma; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Comorbidity; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Expectorants; Humans; Phenotype; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Respiratory System Agents; Severity of Illness Index; Spain; Theophylline

2012
Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke.
    American journal of respiratory and critical care medicine, 2005, Oct-01, Volume: 172, Issue:7

    Topics: Administration, Oral; Aminopyridines; Animals; Benzamides; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Goblet Cells; Hyperplasia; Interleukin-10; Macrophages; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Pulmonary Emphysema; Smoking

2005